Aims: To demonstrate that HCV core antigen can be a reliable means of diagnosing HCV infection in populations that are difficult to engage.
Methods: Levels of HCV core Ag from 109 patients were compared to HCV RNA levels Assay agreement and associations between baseline predictors were investigated using linear regression.
Talal AH, Andrews P, McLeod A, Chen Y,Markatou M, Sylvester C, Brown LS
NIDA Clinical Trials Network Steering Committee (Bethesda, MD), American Society of Addiction Medicine (New Orleans, LA)
Talal AH, Andrews, P, McLeod A, Zeremski M, Chen Y,Markatou M, Sylvester C, Brown LS, Kritz S.
American Public Health Association (Denver, CO)
Brown LS, Talal AH. Increasing Access to Hepatitis C Treatment for Opiate Maintained Patients via Telemedicine. New York State 2016 Clinical Conference on HIV and Hepatitis C (Rochester, NY)
Brown LS, Rustgi V, Reynolds A. Triple E for HCV: Engagement, Education and Eradication of HCV among Patients with Substance Use Disorders. Chronic Liver Disease Foundation (Baltimore, MD)
Brown LS, Talal AH, Zeremski M, Dimova R, Sylvester C, Zavala R, Kritz S. Increasing Access to Hepatitis C Treatment for Opiate Maintained Patients via Telemedicine. American Society of Addiction Medicine (Baltimore, MD)
Talal AH, Andrews P, McLeod A, Zeremski M, Chen Y, Markatou M, Sylvester C, Brown LS. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus (HCV) Management for Individuals on Opioid Agonist Treatment. European Association for the Study of the Liver (Barcelona, Spain)
Brown LS, Sylvester C, Kritz S, Louie B, Zavala R. Using Electronic Information Systems to Improve Outcomes at a Medication-Assisted Treatment Program. Addiction Health Services Research (Marina del Rey, CA)
Brown, LS. Utilization of Telemedicine to Treat Hepatitis C Virus Infection at a Medication-Assisted Treatment Program. OASAS Medical Advisory Panel (New York, NY), American Public Health Association (Chicago, IL)